-
Methylation CYLD cutaneous syndrome
Study
EGAS00001003800
-
Sequencing of cancer autopsies and ctDNA
Study
EGAS00001005109
-
Genomic landscape and PD-1 blockade in Natural-killer/T cell lymphoma
Study
EGAS00001003828
-
Genomic Analysis of Primary Plasma Cell Leukemia reveals Complex Structural Alterations and High Risk Mutational Patterns
Study
EGAS00001003834
-
Whole exome sequencing CYLD cutaneous syndrome
Study
EGAS00001003839
-
Targeted sequencing CYLD cutaneous syndrome
Study
EGAS00001003840
-
RNA sequencing CYLD cutaneous syndrome
Study
EGAS00001003841
-
Osteosarcoma mate-pair and RNA-sequencing
Study
EGAS00001003842
-
Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform
Study
EGAS00001003846
-
WES of melanoma tumors treated with combined immune checkpoint blockade
Study
EGAS00001003857
-
VIKING Health Study - Shetland
Study
EGAS00001003872
-
Whole Genome Sequencing Reveals Potential Therapeutic Strategy for Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
Study
EGAS00001003876
-
Single-cell analysis for metastatic gastric adenocarcinoma
Study
EGAS00001004443
-
Immuno-genomic landscape of osteosarcoma
Study
EGAS00001003887
-
Whole genome and whole transcriptome sequencing of patients diagnosed with angiosarcoma.
Study
EGAS00001003895
-
WES of 2 human osteosarcoma and corresponding cell lines
Study
EGAS00001003923
-
MYO5B mutations in Pheochromocytoma/Paraganglioma promote cancer progression
Study
EGAS00001003991
-
Germline MBD4 Mutations and Predisposition to Uveal Melanoma
Study
EGAS00001003941
-
A Unifying Paradigm for Transcriptional Heterogeneity and Squamous Features in Pancreatic Ductal Adenocarcinoma
Study
EGAS00001003974
-
Sequencing data of multiple sarcoma samples for personalized medicine and endotype identification
Study
EGAS00001003981
-
SCC ctDNA sequencing
Study
EGAS00001003987
-
SCC tumor sequencing
Study
EGAS00001003988
-
Myeloma RNAseq
Study
EGAS00001003999
-
Myeloma WGS
Study
EGAS00001004000
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001